Erector Spinae Plane Block for Analgesia During ESWL

ConditionRenal Stone

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age21-60

SponsorSohag University

About this trial

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult Patients undergoing ESWL with 2-3 cm renal stones

patients between the ages of 21 and 60,

both sexes,

BMI ≥18≤30 kg/m²

Disqualifiers

Coagulopathy or on anticoagulants

Infection at the ESPB injection site

BMI ≥30 kg/m²

Patient refusal.

Trial design

Design model

Parallel

Treatments tested in this trial

erector spinae plane block
Procedure/Surgery
erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy
Nalbuphine
Drug
Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: group A : will receive Erector Spinae Plane Block in the prone position after URS.Active comparator 1 intervention

Group B: group B : will receive nalbuphineActive comparator 1 intervention

Trial outcomes

Primary outcomes

This study aims to evaluate the efficacy of Erector Spinae Plane Block analgesia for patients undergoing ESWL &compare between it and conventional multimodal Analgesia .

postoperative pain by visual analog score from 0 to 10 (where 0 indicates no pain and 10 the worst possible pain

Time frame

6 hours postopertive

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

Apply now